The Global Oligonucleotide Synthesis Market to Hit at A CAGR of 10.1% to 2020
The global oligonucleotide synthesis market is expected to reach USD 1,918.6 Million by 2020 from USD 1,078.1 Million in 2015, at a CAGR of 10.1%. North America commands the largest share in 2015 and expected to witness the second-highest growth rate from 2015 to 2020.
Pune, India – December 15, 2015 /MarketersMedia/ —
Major factors contributing to the growth of the global oligonucleotide synthesis market include increasing R&D expenses in the pharmaceutical and biotechnology companies, rising demand for synthesized oligonucleotides due to the growing field of molecular diagnostics, increasing government investments to develop genomic technologies, rising venture capital investments, and increasing demand for synthetic genes.
Complete report on membranes market spread across 229 pages, profiling 15 companies and supported with 183 tables and 53 figures is now available at http://www.rnrmarketresearch.com/oligonucleotide-synthesis-market-by-product-services-equipment-reagent-primer-probe-custom-oligos-end-user-research-pharmaceutical-biotechnology-application-diagnostics-pcr-qpcr-gen-market-report.html .
Among applications, the research applications segment dominates the market, whereas the diagnostic applications segment is expected to grow at the highest CAGR during the forecast period. Among end users, the diagnostic laboratories segment is expected to grow at the highest CAGR during the forecast period. On the basis of regions, the oligonucleotide synthesis market is segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
North America is expected to account for the largest share of this market in 2015. However, APAC is expected to grow at the highest CAGR during the forecast period, owing to the growing availability of synthesized oligos, increase in R&D funding and activities, and increasing focus of prominent players in in the APAC region.
North America commands the largest share of the global oligonucleotide synthesis market in 2015 and is expected to witness the second-highest growth rate from 2015 to 2020. According to the Centers for Disease Control and Prevention (CDC), in 2014, chronic diseases accounted for 7 out of 10 deaths and 86% of healthcare costs in the U.S. It was reported that ~50% of Americans suffer from at least one chronic disease. Considering the potential of oligonucleotides (therapeutic oligonucleotides) in the treatment of chronic diseases, the oligonucleotide synthesis market is expected to flourish in the coming years, provided these drugs get rapid market approvals.
Apart from the comprehensive regional analysis, product analysis, and market sizing, the report also provides a competitive landscape that covers growth strategies adopted by industry players over the last three years. In addition, the company profiles comprise basic views of key players and their product portfolios, developments, and strategies adopted.
The oligonucleotide synthesis market is highly competitive, with the presence of several big as well as emerging market players. In addition, each product segment has a different set of vendors. Key market players include Agilent Technologies (U.S.), BioAutomation Corporation (U.S.), Biosearch Technologies, Inc. (U.S.), Eurofins Genomics (Germany), Eurogentec (Belgium), GeneDesign, Inc. (Japan), GE Healthcare (U.K.), Integrated DNA Technologies (IDT) (U.S.), Sigma-Aldrich Corporation (U.S.), Thermo Fisher Scientific, Inc. (U.S.), TriLink BioTechnologies, Inc. (U.S.), Gen9, Inc. (U.S.), GenScript (U.S.), and Nitto Denko Avecia Inc. (Japan).
Priced at $4650 for a single user PDF, order a copy of “Oligonucleotide Synthesis Market by Product & Services (Primer, Probe, Custom Oligos, Reagent, Equipment), Application (PCR, Gene Synthesis, Diagnostic, DNA, RNAi), End-User (Research, Pharmaceutical & Biotech, Diagnostic Labs) – Global Forecast to 2020” research report at http://www.rnrmarketresearch.com/contacts/purchase?rname=208277 .
Continuing woth relaed market, Another research titled Active Pharmaceutical Ingredient Market Global Forecast to 2020 saus, The global Active Pharmaceutical Ingredient Market is expected to reach USD 205.51 billion by 2020 from USD 150 billion in 2015, at a CAGR of 6.5% during the forecast period. actors such as the increasing incidence of life style and age related diseases, Increasing prevalence of cancer across the world, Technological advancements in the APIs Manufacturing, Emerging markets for biosimilars and increasing scope for Highly potent active ingredients are driving market growth. Teva Pharmaceuticals limited, Sun Pharmaceuticals Industries Limited, Dr. Reddy’s Laboratories Ltd., Aurobindo, Novartis International AG, Boehringer Ingelheim, Albemarle Corporation, Sigma Aldrich, Mylan and Allergan plc. are companies mentioned in this 207 pages research available at http://www.rnrmarketresearch.com/active-pharmaceutical-ingredient-market-by-type-innovative-generic-type-of-synthesis-synthetic-biotech-type-of-manufacturer-captive-merchant-therapy-oncology-diabetes-orthopedic-cns-nephrology-ophthalmology-global-forecast-to-market-report.html .
About Us:
RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets.
For more information about us, please visit http://www.rnrmarketresearch.com
Contact Info:
Name: Ritesh Tiwari
Organization: RNR Market Research
Address: UNIT no 802, Tower no. 7, SEZ Magarpatta city, Hadapsar
Phone: +1-888-391-5441
Release ID: 99181
Copyright © 1999-2013 SproutNews.com
